Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system

Thrombosis Research

Volumn 100, Issue 4, 2000, Pages 341-351

  Ries, Martin ^a,b   Zenker, Martin ^b   Gaffney, Patrick J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Neonates; Plasminogen; Single chain urokinase plasminogen activator; Urokinase

Indexed keywords

AMINOCAPROIC ACID; CARBOHYDRATE; FETOPROTEIN; FIBRIN; GLUTAMIC ACID; ISOPROTEIN; LYSINE; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PROUROKINASE; TRANEXAMIC ACID; UROKINASE;

ADULT; AGE; ARTICLE; CATALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; KINETICS; NEWBORN; NORMAL HUMAN; PLASMINOGEN ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

6-AMINOCAPROIC ACID; ADULT; AGING; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; FIBRIN; FIBRINOLYSIS; HUMANS; INFANT, NEWBORN; KINETICS; PEPTIDE FRAGMENTS; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PROTEIN ISOFORMS; SOLUBILITY; TRANEXAMIC ACID; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034668795     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00322-4     Document Type: Article

References (45)

1. Basic and clinical aspects of fibrinolysis and thrombolysis
2. The plasminogen activator/plasmin system
3. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity
4. The activation of human [Glu1]plasminogen by human single-chain urokinase
5. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)
6. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin
7. Urokinase-type plasminogen activator; proenzyme, receptor, and inhibitors
8. The role of the plasminogen activation system in cancer
9. Involvement of the plasminogen activator/plasmin proteolytic cascade in fertilization
10. Angiogenesis; a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis
11. Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain
12. Plasminogen activators in tissue remodeling and invasion; mRNA localization in mouse ovaries and implanting embryos
13. Bovine embryos produce a urokinase-type plasminogen activator
14. Embryo implantation in mouse; fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes
15. Urokinase receptor-deficient (uPAR-/-) mice showed impaired pulmonary defense during pneumococcal pneumonia
16. Differential development of hypoxia-induced pulmonary hypertension and right ventricular hypertrophy in transgenic mice with various deficiencies in the plasminogen/plasmin system
17. Developmental hemostasis; relevance to thromboembolic complications in pediatric patients
18. Molecular and functional properties of fetal plasminogen and its possible influence on clot lysis in the neonatal period
19. Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein
20. Plasminogen; Purification from human plasma by affinity chromatography
21. Measurement of the binding of antifibrinolytic amino acids to various plasminogens
22. Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations
23. Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration
24. A comparison of cultured cells with other promotors of tissue plasminogen activator kinetics
25. A modified beta-alanine precipitation procedure to prepare fibrinogen free of antithrombin III and plasminogen
26. Purification of human and bovine fibrinogen
27. Kinetics of plasmin activation of single chain urinary- type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen
28. Activation of pro-urokinase by plasmin; non-Michaelian kinetics indicates a mechanism of negative cooperativity
29. Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen
30. Sialic acid and enzymatic desialation of cord blood fibrinogen
31. Fetales Fibrinogen
32. Evidence for the existence of foetal fibrinogen
33. Comparison of human normal, full-term, fetal and adult plasminogen by physical and chemical analyses
34. Newborn's fibrinolytic mechanism; Components and plasmin generation
35. Physiological activation of plasminogen in full term newborn infants
36. In vitro fibrinolysis after adding low doses of plasminogen activators and plasmin generation with and without oxidative inactivation of plasmin inhibitors in newborns and adults
37. Thrombolytic therapy in pediatric patients; a comprehensive review of the literature
38. Intracerebral hemorrhage during fibrinolytic therapy in children; a review of the literature of the last thirty years
39. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin
40. The kringle domains of human plasminogen
41. 1) plasminogen by human tissue plasminogen activator
42. The influence of the nature of the asparagine 289-linked oligosaccharide on the activation by urokinase and lysine binding properties of natural and recombinant human plasminogens
43. Role of lysine binding regions in the kinetic properties of human plasmin